It is a real estate private limited company based in Egmore, Chennai 8, Tamil Nadu, India, established in 1993.
1993 | Egmore, Chennai 8, Tamil Nadu, India | AmalgamatedOakley Bowden Pharma Private Limited, a amalgamated private limited company, was established on 07 May 1993 in Egmore, Chennai 8, Tamil Nadu, India. Engaging in real estate leasing within the real estate sector, it holds CIN: U24231TN1993PTC025025. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹1.63 M.
It upholds a compliant status. Its leadership includes Kishor Lal Daga (Director), Thiyagarajan (Additional Director). Past directors included Siddhartha Daga, Suresh Kumar Sewag. It holds no open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 December 2020, with the balance sheet filed on 31 March 2020. It is based at Unit N O 9B 3Rd Floorr A Building No 72, Marshalls Road, Egmore, Chennai 8, Tamil Nadu, 600008.
U24231TN1993PTC025025
025025
07 May 1993
₹4.50 M
₹1.63 M
Roc Chennai
Unlisted
Amalgamated
Explore comprehensive insights into Oakley Bowden Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kishor Lal Daga | Director | 01 Nov 2009 | Current |
| Thiyagarajan | Additional Director | 22 Jan 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2009 | Past |
| Pramod Abcsdd | Director | 22 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oakley Bowden Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Oakley Bowden Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jan 2004 | State Bank Of India | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Oakley Bowden Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oakley Bowden Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oakley Bowden Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Thiyagarajan was appointed as a Additional Director was appointed as a Additional Director on 22 Jan 2021 & has been associated with this company since 4 years 10 months . was documented.
Oakley Bowden Pharma Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records. was recorded as a recent event.
The activity Oakley Bowden Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Chennai. was completed.
A charge registered on 07 Jan 2004 via Charge ID 90281593 with State Bank Of India was fully satisfied on 02 Aug 2017. was recorded as a recent event.
The activity Kishor Lal Daga was appointed as a Director was appointed as a Director on 01 Nov 2009 & has been associated with this company since 16 years 30 days . was completed.
Progress on A charge with State Bank Of India amounted to Rs. 5.00 M with Charge ID 90281593 was registered on 07 Jan 2004. was documented.
The CIN of Oakley Bowden Pharma Private Limited is U24231TN1993PTC025025.
Oakley Bowden Pharma Private Limited is headquartered at Unit N O 9B 3Rd Floorr A Building No 72, Marshalls Road, Egmore, Chennai 8, Tamil Nadu, 600008.
Oakley Bowden Pharma Private Limited was incorporated on 07 May 1993.
The current directors of Oakley Bowden Pharma Private Limited are
The primary industry of Oakley Bowden Pharma Private Limited is Real Estate.
Oakley Bowden Pharma Private Limited is unlisted.
The authorized capital of Oakley Bowden Pharma Private Limited is ₹4.50 M, and the paid-up capital is ₹1.63 M.
The compliance status of Oakley Bowden Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX